[ Price : $8.95]
Federal Register notice: FDA revokes Battelle Memorial Institutes emergency use authorization for the Battelle Critical Care Decon...[ Price : $8.95]
Federal Register notice: FDA revokes a BioFire Diagnostics emergency use authorization for its BioFire Respiratory Panel 2.1 after...[ Price : $8.95]
FDA approves Amgens Lumakras (sotorasib) for treating adult patients with non-small cell lung cancer whose tumors have the KRAS G1...[ Price : $8.95]
The DC Circuit Court of Appeals affirms a lower court decision recognizing FDAs authority to place homeopathic drugs on its import...[ Price : $8.95]
FDAs fiscal year 2022 budget request seeks an 8% ($477 million) boost for agency activities.[ Price : $8.95]
Federal Register notice: FDA withdraws a notice by the previous administration that would have ended the agencys unapproved drugs ...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Procedures for Handling Post-Approval Studies Imposed by Pr...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Postmarket Surveillance Under Section 522 of the Federal Fo...